Stem cell transplant for acute lymphocytic leukemia

Some people with acute lymphocytic leukemia (ALL) will have a stem cell transplant. Stem cells are found in the bone marrow, the bloodstream and umbilical cords. They are basic cells that develop into different types of cells that have different jobs. For example, all our blood cells develop from blood stem cells.

A stem cell transplant is used to replace stem cells when stem cells or bone marrow are damaged. They can be damaged by disease or destroyed by high doses of chemotherapy or radiation therapy. You may be offered a stem cell transplant to treat ALL:

  • during first complete remission
  • following relapse if a partial or complete remission can be reached

A stem cell transplant is a very risky and complex procedure that must be done in specialized transplant centres or hospitals.

Types of transplants used for ALL

The following types of stem cell transplant may be used with ALL.


In this type of transplant, the stem cells are taken from one person (the donor) and are given to another person (the recipient). The donor may be a relative or may be unrelated to the recipient. The donor and recipient are matched through a process called human leukocyte antigen (HLA) typing.

An allogeneic transplant is the preferred type of stem cell transplant used to treat ALL. But not everyone can have an allogeneic transplant because they need to have a matched donor.

The side effects of the high doses of chemotherapy used before a stem cell transplant may be too severe for people over 55 years of age. People in this age group may also have other health conditions that mean they can’t have an allogeneic transplant. They may be offered a reduced-intensity transplant, which uses lower-dose conditioning treatment.


In this type of transplant, the stem cells are taken from your own bone marrow or blood. An autologous transplant is sometimes used if there is no matched donor.

Side effects

Side effects can happen with any type of treatment for ALL, but everyone’s experience is different.

Side effects can develop any time during, immediately after or a few days or weeks after a stem cell transplant. Sometimes late side effects develop months or years after a stem cell transplant. Most side effects go away on their own or can be treated, but some side effects may last a long time or become permanent.

Side effects of a stem cell transplant will depend mainly on the type of chemotherapy drug or drug combination given, if radiation therapy was given, the type of transplant and your overall health. Common side effects of a stem cell transplant include:

Tell your healthcare team if you have side effects that you think might be from a stem cell transplant. The sooner you tell them of any problems, the sooner they can suggest ways to help you deal with them.

Questions to ask about stem cell transplant

Find out more about stem cell transplant and side effects of stem cell transplant. To make the decisions that are right for you, ask your healthcare team questions about stem cell transplant.

Expert review and references

  • American Cancer Society. Leukemia - Acute Lymphocytic (Adults). Atlanta, GA: American Cancer Society; 2013.
  • Ezzone SA . Principles and techniques of blood and marrow translplantation. Yarbro, CH, Wujcki D, & Holmes Gobel B. (eds.). Cancer Nursing: Principles and Practice. 7th ed. Sudbury, MA: Jones and Bartlett; 2011: 18: pp. 504-512.
  • Goekbuget N, Hoelzer D . Diagnosis and Treatment of adult acute lymphoblastic leukemia. Wiernik PH, Goldman JM, Dutcher JP & Kyle RA (eds.). Neoplastic Diseases of the Blood. 5th ed. Springer; 2013: 20: pp. 331-354.
  • Kebriaei P, Champlin R, de Lima M, et al . Management of acute leukemias. DeVita VT Jr, Lawrence TS, & Rosenberg SA. Cancer: Principles & Practice of Oncology. 9th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2014: 131: pp. 1928-1954.
  • National Cancer Institute. Adult Acute Lymphoblastic Leukemia Treatment (PDQ®) Health Professional Version. Bethesda, MD: National Cancer Institute; 2014.